June 2014
·
27 Reads
·
6 Citations
The Journal of family practice
No, there is no high-quality evidence that supports using complementary or alternative agents to lower hemoglobin A1c (HbA1c) in patients with noninsulin-dependent type 2 diabetes. Oral chromium in widely varying doses reduces HbA1c a small amount.